About us

Revenio in brief

A global leader in ophthalmic diagnostics

Revenio is a global leader in ophthalmic diagnostics and ophthalmic devices. Revenio Group's ophthalmic diagnostic solutions include intraocular pressure measurement devices under the iCare brand, retinal imaging devices and perimeters. The main tools for the detection and diagnosis of glaucoma and its monitoring during treatment are intraocular pressure measurement (tonometry), retinal imaging, and visual field tests (perimetry).

The Revenio Group comprises Revenio Group Corporation, Icare Finland Oy, Icare USA Inc., Revenio Italy S. R. L, CenterVue SpA, Revenio Research Oy, Revenio Australia Pty Ltd, Icare World Australia Pty Ltd, CT Operations International UK Ltd, Done Medical Oy and Oscare Medical Oy.

Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V.


Read more about sustainability at Revenio


Read more about the quality goals of Revenio